Active substance
Nicotine polacrilex
- SFDA 4
- US FDA 60
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| NIQUITIN 2MG MINT LOZENGE | 2 mg | Lozenge · Oral use | 24 Bottle | SAR 31.80 | Generic · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| NIQUITIN 2MG MINT LOZENGE | 2 mg | Lozenge · Oral use | 48 Bottle | SAR 47.30 | Generic · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| NIQUITIN 4MG MINT LOZENGE | 4 mg | Lozenge · Oral use | 24 Bottle | SAR 31.80 | Generic · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| NIQUITIN 4MG MINT LOZENGE | 4 mg | Lozenge · Oral use | 48 Bottle | SAR 47.30 | Generic · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NICORETTE | EQ 2MG BASE | gum, chewing · buccal | HALEON US HOLDINGS | Over-the-counter | 13 Jan 1984 |
| NICORETTE (MINT) | EQ 2MG BASE | gum, chewing · buccal | HALEON US HOLDINGS | Over-the-counter | 13 Jan 1984 |
| NICORETTE | EQ 4MG BASE | gum, chewing · buccal | HALEON US HOLDINGS | Over-the-counter | 8 Jun 1992 |
| NICORETTE (MINT) | EQ 4MG BASE | gum, chewing · buccal | HALEON US HOLDINGS | Over-the-counter | 8 Jun 1992 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 15 Mar 1999 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 19 Mar 1999 |
| NICORETTE | EQ 2MG BASE; EQ 4MG BASE | troche/lozenge · oral | HALEON US HOLDINGS | Over-the-counter | 31 Oct 2002 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 29 Jul 2004 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 29 Jul 2004 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | L PERRIGO CO | Over-the-counter | 16 Sep 2004 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | L PERRIGO CO | Over-the-counter | 16 Sep 2004 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | L PERRIGO CO | Over-the-counter | 16 Sep 2004 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | L PERRIGO CO | Over-the-counter | 16 Sep 2004 |
| NICOTINE POLACRILEX | EQ 2MG BASE; EQ 4MG BASE | troche/lozenge · oral | PERRIGO R AND D | Over-the-counter | 31 Jan 2006 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | PERRIGO R AND D | Over-the-counter | 30 Oct 2006 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | PERRIGO R AND D | Over-the-counter | 30 Oct 2006 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | PERRIGO R AND D | Over-the-counter | 24 May 2007 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | PERRIGO R AND D | Over-the-counter | 24 May 2007 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 29 Dec 2008 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 29 Dec 2008 |
| NICORETTE | EQ 2MG BASE; EQ 4MG BASE | troche/lozenge · oral | HALEON US HOLDINGS | Over-the-counter | 18 May 2009 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 8 Jul 2009 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 8 Jul 2009 |
| NICOTINE POLACRILEX | EQ 2MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 8 Jul 2009 |
| NICOTINE POLACRILEX | EQ 4MG BASE | gum, chewing · buccal | P AND L | Over-the-counter | 8 Jul 2009 |
35 more — full table
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.